This is not the most recent version of the article. View current version (27 JUL 2015)

Intervention Protocol

You have free access to this content

Mepolizumab versus placebo for asthma

  1. Colin Powell1,*,
  2. Stephen J Milan2,
  3. Kerry Dwan3,
  4. Nicola Walters4

Editorial Group: Cochrane Airways Group

Published Online: 15 NOV 2013

DOI: 10.1002/14651858.CD010834


How to Cite

Powell C, Milan SJ, Dwan K, Walters N. Mepolizumab versus placebo for asthma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010834. DOI: 10.1002/14651858.CD010834.

Author Information

  1. 1

    Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Department of Child Health, Cardiff, UK

  2. 2

    St George's, University of London, Population Health Sciences and Education, London, UK

  3. 3

    University of Liverpool, Department of Biostatistics, Liverpool, England, UK

  4. 4

    St George's NHS Healthcare Trust, Chest Unit, London, UK

*Colin Powell, Department of Child Health, Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, UK. PowellC7@cardiff.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 15 NOV 2013

SEARCH

This is not the most recent version of the article. View current version (27 JUL 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of mepolizumab with placebo on exacerbations and HRQoL in adults and children with chronic asthma.